Prevalence and control of type 2 diabetes mellitus among primary care physicians in Spain. PRISMA Study

Autor: David Asensio, Josep Franch-Nadal, M Mata-Cases, Javier Mediavilla-Bravo, Didac Mauricio, Jordi Sarroca
Rok vydání: 2017
Předmět:
Male
endocrine system diseases
Disease
0302 clinical medicine
Prevalence
030212 general & internal medicine
Prediabetes
Hypolipidemic Agents
education.field_of_study
Smoking
Type 2 diabetes
Middle Aged
Primary care
Lipids
Hypertension
Female
Adult
medicine.medical_specialty
Attitude of Health Personnel
Population
030209 endocrinology & metabolism
Physicians
Primary Care
Sampling Studies
Medication Adherence
Prediabetic State
03 medical and health sciences
Internal medicine
Physicians
medicine
Humans
Hypoglycemic Agents
National level
HbA(1c)
education
Antihypertensive Agents
Dyslipidemias
Glycated Hemoglobin
business.industry
nutritional and metabolic diseases
Type 2 Diabetes Mellitus
medicine.disease
Surgery
Self Care
Blood pressure
Cross-Sectional Studies
Diabetes Mellitus
Type 2
Spain
Metabolic control analysis
business
mellitus
Zdroj: Endocrinologia Diabetes y Nutricion
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
ISSN: 2530-0172
2530-0180
Popis: Objective: To describe the prevalence of known and ignored type 2 diabetes mellitus (T2DM) among primary care physicians (PCP), as well as the treatment used and the degree of metabolic control reached. Material and methods: Descriptive cross-sectional study on national level. The participants were randomly selected PCPs, members of the redGDPS Foundation. A total of 495 PCP were enrolled. Capillary HbA(1c) measurement was done with a A1CNow+(R) device and a diabetes-related survey specifically designed for the study was administered to the participants. Results: The total prevalence of T2DM was 11.1% (95% CI 8.33-13.9) (known disease 8.1% and ignored disease 3.0%). The prevalence of prediabetes was 16.2% (95% CI 13.0-19.4). A total of 62.5% of PCPs with known T2DM reached HbA(1c) < 7% and 15% had HbA(1c) > 8.5%. Control of blood pressure (BP < 140/90 mmHg) was reached in 87.5% and control of LDL cholesterol < 130 mg/dl with no history of cardiovascular disease was reached in 88.6% of cases of known T2DM. In the PCPs with a history of macrovascular disease, good control of LDL was reached in 42.9% of the cases. A total of 12.5% were active smokers. A total of 71.4% of PCPs with known T2DM self-treated their own disease, usually with 2 or more drugs (51.4%). The most commonly used drug was metformin (74.3%) followed by iDPP4 (48.6%). Conclusions: PCPs with T2DM have better metabolic control than the general population. It is necessary to study whether PCPs with T2DM may have greater adherence to treatment and do they achieve a better metabolic control. (C) 2017 SEEN. Published by Elsevier Espana, S.L.U. All rights reserved.
Databáze: OpenAIRE
Externí odkaz: